Fundstrat Research

Fundstrat


Fundstrat on Interactive Brokers

To subscribe to Fundstrat, log in to Client Portal, then select Menu - Settings - User Settings - Research Subscriptions (Configure Gear icon) - Current Subscriptions (Configure Gear icon)


FSinsight.com produces primary research along the following verticals:

(i) Portfolio Strategy led by Thomas Lee a widely-recognized market authority and commentator, whose views regularly appear in the media. (He was formerly at J.P. Morgan (1999-2014), where he was chief equity strategist from 2007 to 2014.

(ii) Quantitative Strategy led by Sam Doctor (head of data science research, former US small and mid-cap technology analyst and India small / mid cap strategist at J.P. Morgan);

(iii) Technical Analysis Strategy led by Robert Sluymer (Senior technical strategist with over 26 years of experience at RBC Capital Markets).

(iv) Washington Policy Strategy led by Tom Block (president of Tom Block Consults, a public-policy consulting firm. Prior to that, Mr. Block had a 21-year career at J.P. Morgan, serving as global head of government relations).

FSinsight.com's Quantitative Indices (managed by Sam Doctor/Ken Xuan) are widely followed by clients. The research team has nearly 80 combined years of institutional sell-side research experience. Their approach is data intensive and seeks to take advantage of anomalies that identify sectors and stocks which have the potential to outperform the market. Tools are aligned with this focus and help clients to make better informed decisions. FSinsight.com concentrates on delivering analysis, not opinions, and as an independent research provider, clients are assured that the work is tailored to provide fresh and innovative intelligence to aid in their investment process.


View Sample Report *Visit Website

Disclosures
  • * This sample research report is published by Fundstrat and is being posted with permission from Fundstrat. The views expressed in this article are solely those of the author and/or Fundstrat and IB does not endorse or recommend any investment, trades or trading strategies discussed in the article. This material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IB to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.